CNBCTV18

US FDA flags 11 procedural observations at Eugia Pharma’s Telangana unit

The US Food and Drug Administration (US FDA) has completed a current good manufacturing practice (CGMP) inspection at ...
CNBCTV18

Aurobindo Pharma shares drop 4% after US FDA flags lapses at Unit-7

The US FDA had inspected Aurobindo's Unit-7 between January 28 and February 10, 2026. The inspection observations pointed to ...

U.S. FDA issues 9 observations to Aurobindo Pharma unit

The U.S. Food and Drug Administration (U.S. FDA) has issued nine observations to the oral solid dosage manufacturing unit of generic drugmaker Aurobindo Pharma near Hyderabad.
Medical Dialogues

USFDA Issues 9 Observations to Aurobindo's Jedcherla Unit-VII After Inspection

Aurobindo Pharma Limited recently informed that the United States Food and Drug Administration (USFDA) has completed an inspection at its Unit-VII manufacturing facility located ...
Pharmabiz

US FDA completes inspection of Anuh Pharma’s facilities at Tarapur MIDC with no Form 483 observations

US FDA completes inspection of Anuh Pharma’s facilities at Tarapur MIDC with no Form 483 observations: Our Bureau, Bengaluru Monday, February 9, 2026, 15:30 Hrs [IST] US drug re ...
FiercePharma

Under FDA scrutiny, Aurobindo's Eugia tallies a 5th Form 483 in less than a year

Eugia remains under FDA scrutiny as the unit of Indian drugmaker Aurobindo has received its fifth Form 483 since December. The company’s latest slap from the U.S. regulator stems from an April 25 to ...